Aligos
is a California-based stage biotechnology company that researches and develops novel therapies for the treatment of liver and viral diseases.. Read moreAligos
is a California-based stage biotechnology company that researches and develops novel therapies for the treatment of liver and viral diseases.. Read more
News
May 27, 2026
Benzinga
Aligos: Aligos Therapeutics Presents Positive Data at the EASL Congress 2026
May 27, 2026
Nasdaq
Aligos: Aligos Presents Promising Data For Pevifoscovir Sodium In Treating Hepatitis B
May 13, 2026
Benzinga
Aligos: Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026
May 08, 2026
Owler
Aligos Therapeutics, Inc.: Aligos's revenue changed from $2.19M in Dec 2025 to $4.71M in Mar 2026
May 08, 2026
RTTNews
Aligos: Aligos Therapeutics Posts Narrower Q1 Loss, Highlights Pipeline Progress; Stock Up
Apr 30, 2026
Yahoo
Aligos: Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026
Apr 24, 2026
RTTNews
Aligos: Aligos Therapeutics Grants Equity Awards To New Employees Under Nasdaq Rule 5635 (c)(4), Stock Up
Apr 17, 2026
Pharmaceutical Business Review
Aligos: Aligos and Xiamen Amoytop sign deal for HBV therapy
Apr 16, 2026
FierceBiotechIT
Aligos: Aligos sells China rights to HPV drug to hepatology player Amoytop in $445M deal.
Apr 16, 2026
Benzinga
Aligos: Aligos Therapeutics Says China Pact Puts HBV Drug In Focus Amid Trial Updates
